Analyst Ratings for Can-Fite BioPharma (CANF)
CANF Rating Summary
CANF Price Target Summary
- Highest: $2.50 (H.C. Wainwright)
- Lowest: $2.50 (H.C. Wainwright)
- Average: $2.50
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$2.50 (-45.1%)
* Over Last 12-Mos
Rating Score: 4 / 10
Percentile Rank: 39%
Avg. $ Target:
$2.50 (-45.1%)
* Over Last 12-Mos
Rating Score: 4 / 10
Percentile Rank: 39%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/24/2025 | D. Boral Capital | Jason Kolbert | Downgrade | Hold (Buy) |
N/A (N/A) |
0.24 (4.55) |
1795.83% | Details |
| 11/4/2025 | H.C. Wainwright | Swayampakula Ramakanth | New Coverage | Buy (N/A) |
2.50 (N/A) |
0.41 (4.55) |
1009.76% | Details |
 |
||||||||
|
||||||||
|
||||||||
